Financhill
Back

Catalyst Pharmaceuticals Quote, Financials, Valuation and Earnings

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade
Buy
57

CPRX
Catalyst Pharmaceuticals

Last Price:
21.95
Seasonality Move:
-2.02%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Catalyst Pharmaceuticals Price Quote

$21.95
-0.01 (0.97%)
(Updated: November 6, 2024 at 5:04 AM ET)

Catalyst Pharmaceuticals Key Stats

Buy
57
Catalyst Pharmaceuticals (CPRX) is a Buy

Day range:
$21.41 - $22.05
52-week range:
$12.27 - $22.27
Dividend yield:
0%
P/E ratio:
34.86
P/S ratio:
5.92
P/B ratio:
4.28%

Volume:
872.5K
Avg. volume:
753.2K
1-year change:
66.87%
Market cap:
$2.6B
Revenue:
$398.2M
EPS:
$0.54

How Much Does Catalyst Pharmaceuticals Make?

Is Catalyst Pharmaceuticals Growing As A Company?

Catalyst Pharmaceuticals Stock Price Performance

What Is Catalyst Pharmaceuticals 52-Week High & Low?

Catalyst Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Catalyst Pharmaceuticals?

Is Catalyst Pharmaceuticals Cash Flow Positive?

  • What Is CPRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $196.8M
  • What Is Catalyst Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $131.4M
  • What Is Catalyst Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$131.3M

Catalyst Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    CPRX return on invested capital is 14.93%
  • What Is Catalyst Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 12.71%
  • What Is CPRX Return On Equity?
    ROE is a measure of profitability and is 14.93%

Catalyst Pharmaceuticals Earnings Date & Stock Price

Catalyst Pharmaceuticals Competitors

Catalyst Pharmaceuticals Dividend Yield

Catalyst Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 31.45%
Revenue: 23.23% 9.69%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 30.29
Upside from Last Price: 37.91%

Major Shareholders

  • How many CPRX shares are owned by institutional investors?
    171.9M CPRX shares are owned by institutional investors
  • How many CPRX shares are owned by insiders?
    9.4M CPRX shares are owned by insiders